JSC “BioChimPharm” participated in the symposium organized by the European Bank for Reconstruction and Development (EBRD), which was focused on combating antibiotic resistance (AMR). According to the World Health Organization (WHO), AMR is one of the world’s most critical problems.

Rati Golijashvili, the general manager of JSC “BioChimPharm,” presented at the symposium the unique phage technology and the successful modernization project of BioChimPharm’s historical phage factory.

The symposium was held on April 18 at the EBRD headquarters in London, Great Britain.